secwatch.observer — SEC 8-K summary
======================================

Issuer:     Esperion Therapeutics, Inc. (ESPR)
CIK:        0001434868
Form:       8-K
Filed at:   2024-01-18T23:59:59+00:00
Accession:  0001104659-24-004800
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Esperion Therapeutics discloses preliminary cash balance of $82M as of Dec 29, 2023
--------------------------------------------------------------------------------

- Preliminary cash, cash equivalents and short-term investments total $82.0M as of December 29, 2023.
- Amount is preliminary and subject to completion of financial closing procedures.
- Full quarterly and year-end financial results for December 31, 2023 not yet released.
- Ernst & Young has not audited or reviewed this preliminary data.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1434868/000110465924004800/0001104659-24-004800-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1434868/000110465924004800/tm243338d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-004800

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer